Contribution of equilibrative nucleoside transporter(s) to intestinal basolateral and apical transports of anticancer trifluridine-Reference-Cited by-同舟云学术

Contribution of equilibrative nucleoside transporter(s) to intestinal basolateral and apical transports of anticancer trifluridine

Published:2017-12-15 Issue:1 Volume:39 Page:38-46
ISSN:0142-2782
Container-title:Biopharmaceutics & Drug Disposition
language:en
Short-container-title:Biopharm Drug Dispos

Author:

Takahashi Koichi¹²^ORCID,Yoshisue Kunihiro¹,Chiba Masato¹,Nakanishi Takeo²,Tamai Ikumi²

Affiliation:

1. Pharmacokinetics Research Laboratories, Discovery and Preclinical Research Division; Taiho Pharmaceutical Co. Ltd; Tsukuba Ibaraki Japan

2. Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences; Kanazawa University; Kakuma-machi Kanazawa Japan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,General Medicine

Reference22 articles.

1. Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line;Crawford;Journal of Biological Chemistry,1998

2. In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans;Dawson;Drug Metabolism and Disposition,2012

3. Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours;Doi;British Journal of Cancer,2012

4. An optimal dosing schedule for a novel combination antimetabolite, TAS-102, based on its intracellular metabolism and its incorporation into DNA;Emura;International Journal of Molecular Medicine,2004

5. In situ hybridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placenta;Govindarajan;American Journal of Physiology Regulatory Integrative Comparative Physiology,2007

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TAS-102, Irinotecan, and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO), a phase II clinical trial;British Journal of Cancer;2024-09-07

2. Maternal and Fetal Expression of ATP-Binding Cassette and Solute Carrier Transporters Involved in the Brain Disposition of Drugs;Advances in Maternal-Fetal Biomedicine;2023

3. Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment;Frontiers in Pharmacology;2022-08-16

4. Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, A Potential Oral Drug Candidate for COVID-19 Treatment;2022-02-07

5. Pyrimidine-based anticancer drugs;New Strategies Targeting Cancer Metabolism;2022